Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources

ESMO Congress 2024

13 - 17 Sep 2024

Barcelona

ESMO-Congress-2024-1000x1000

Resources are available according to the presenters' agreement to release them.

  • Abstracts, ePosters and Guidelines sessions are open access.
  • Slides and webcasts are reserved to ESMO Members and registered Delegates.

The copyright protected educational resources from this event are for personal usage only and not to be shared with any third parties. ESMO thanks the authors for their generosity.

Meeting programme Next/upcoming meetings
For healthcare professionals, researchers, and those interested in the ever-evolving field of cancer research and care

The ESMO 2024 comprehensive educational and scientific program fostered exchange and debate on translational cancer science, presented groundbreaking data, and encouraged multidisciplinary discussions to improve patient treatment. It also provided updates on cancer prevention, screening, and research breakthroughs, analyzed clinical perspectives, and enhanced understanding of novel diagnostics and treatments.

Clinical Practice Guidelines Sessions:
Session 1: Epithelial ovarian | metastatic colorectal 
Session 2: Renal-cell carcinoma | management of venous thromboembolism
ESMO-MCBS: Magnitude of Clinical Benefit Scale
ESMO Colloquia:
ESMO Colloquia slides and webcasts
Industry Satellite Symposia:
Industry Satellite Symposia webcasts

More Resources:
ESMO Congress 2024 Breaking Science Video Series

Hide
Filter by:
Search:
Reset

There are 3164 resources available

Panel discussion and audience Q&A

Presenter: Martin Wermke, Gerrina Ruiter, Jon Zugazagoitia

Session: Boehringer Ingelheim - Emerging therapies in clinical practice: What are the patient perspectives on the future of lung cancer treatment?

Resources:

Webcast

Closing Remarks

Presenter: Laurence Albiges

Session: Bristol Myers Squibb - Developments in Genitourinary Cancer Management: Joint Decision Making in MIUC and Advanced RCC

Resources:

Webcast

Panel discuss

Presenter: Umberto Malapelle, Magdalena Meissner, Åslaug Helland, Stephen Rowley

Session: Illumina - Liquid biopsy-based biomarkers for cancer profiling and monitoring: current and future applications

Resources:

Webcast

Meeting close

Presenter: Tony S.K. Mok

Session: Pfizer Oncology - Setting a new benchmark for ALK+ aNSCLC targeted therapy

Resources:

Webcast

Presentation by Expert

Presenter: Won Seog Kim

Session: New horizons in T cell lymphoma: From classification to clinic

Resources:

Slides

Webcast

Discussion led by Chair

Presenter: Francesco D'Amore

Session: New horizons in T cell lymphoma: From classification to clinic

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.